Skip to main content
Log in

44th Annual Meeting of the Drug Information Association

22–26 June 2008; Boston, Massachusetts, USA

  • Meeting Report
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 1The use of trade names is for product identification purposes only and does not imply endorsement

References

  1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Revision of the ICH guideline on clinical safety data management data elements for transmission of individual case safety reportsE2B(R3) [online]. Available from URL: International Conference on Harmonisation (ICH) E2B [Accessed 2008 Jul 14]

    Google Scholar 

  2. US Food and Drug Administration. Guidance for industry. Drug-induced liver injury: premarketing clinical evaluation [online]. Available from URL: http://www.fda.gov/cder/guidance/7507dft.htm [Accessed 2008 Jul 14]

    Google Scholar 

  3. EMEA. ICH Topic E2F: development safety update report. Step 3: note for guidance on development safety update report. EMEA/CHMP/ICH/309348/2008 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/ich/30934808en.pdf [Accessed 2008 Jul 14]

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pochon, S. 44th Annual Meeting of the Drug Information Association. Pharm Med 22, 245–250 (2008). https://doi.org/10.1007/BF03256709

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256709

Keywords

Navigation